Evoke Pharma Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Solana Beach, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Evoke Pharma Inc has filed 665 SEC EDGAR filings since 11 Jun 2007

SEC filing history

Showing 376-400 of 662 matching filings.

Per page
25
Current page
16
CT ORDER File 001-36075

CT ORDER filing

Filing date
20 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
04 Jun 2018
Reporting date
04 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-224897

S-8 14MAY2018

Filing date
14 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - Q1 EARNINGS

Filing date
14 May 2018
Reporting date
14 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - MEXICAN PATENT

Filing date
10 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87872

SC 13G

Filing date
08 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - EUROPEAN PATENT

Filing date
30 Apr 2018
Reporting date
30 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - ANNUAL MEETING RESULTS 2018

Filing date
27 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36075

CT ORDER filing

Filing date
18 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36075

8-K/A 6APR2018

Filing date
06 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
04 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - MALLINCKRODT

Filing date
26 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
23 Mar 2018
Reporting date
22 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36075

DEFA14A

Filing date
16 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36075

DEF 14A - 2017

Filing date
16 Mar 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .